R-PCI study

R-PCI study - R-PCI study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007780

Enrollment

100

Registered

2012-04-25

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease

Interventions

high-dose therapy Standard-dose therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergo percutaneous coronary intervention with drug-eluting stents. Patients who have an LDL cholesterol level at entry that is higher than 100 mg per deciliter.

Exclusion criteria

Exclusion criteria: Patients have malignant tumor, renal dysfunction, collagen diseases, inflammatory bowel diseases, interstitial pneumonia, asthma or liver disease. Pregnant women were excluded.

Design outcomes

Primary

Measure	Time frame
anti-inflammatory effect	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026